Topics

Akebia Therapeutics to Participate in Upcoming Investor Conferences

08:00 EDT 29 May 2019 | Businesswire

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease, today announced that John P. Butler, President and Chief Executive Officer of Akebia, will participate in the following investor conferences:

  • The Jefferies 2019 Healthcare Conference on Tuesday, June 4th at 3:00 p.m. Eastern Time at the Grand Hyatt New York.
  • The Raymond James Life Sciences and MedTech Conference on Wednesday, June 19th at 10:55 a.m. Eastern Time at the Lotte New York Palace.

A live webcast of the presentations will be available on the company’s website at www.akebia.com. A replay of the webcast will be available on Akebia’s website following the conference.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for patients with kidney disease. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Kristen K. Sheppard, Esq
VP, Investor Relations
ksheppard@akebia.com

NEXT ARTICLE

More From BioPortfolio on "Akebia Therapeutics to Participate in Upcoming Investor Conferences"

Quick Search

Relevant Topics

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...